1.
Int J Gynecol Cancer
; 34(5): 777-782, 2024 May 06.
Article
in English
| MEDLINE
| ID: mdl-38719275
Subject(s)
Antibodies, Monoclonal, Humanized , Antineoplastic Combined Chemotherapy Protocols , Bevacizumab , Carcinoma, Small Cell , Cyclophosphamide , Ovarian Neoplasms , Humans , Female , Bevacizumab/administration & dosage , Cyclophosphamide/administration & dosage , Antibodies, Monoclonal, Humanized/administration & dosage , Antibodies, Monoclonal, Humanized/therapeutic use , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Ovarian Neoplasms/drug therapy , Ovarian Neoplasms/pathology , Carcinoma, Small Cell/drug therapy , Carcinoma, Small Cell/pathology , Hypercalcemia/drug therapy , Middle Aged
2.
Breast J
; 23(6): 757-759, 2017 11.
Article
in English
| MEDLINE
| ID: mdl-28892224